Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant

Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant

<strong>Background:</strong> Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers have shown that lenalidomide is capable of ameliorating the immune system factors and antitumor res...

Full description

Bibliographic Details
Main Authors: Kiandokht Borhani, Taravat Bamdad, Tayebeh Hashempour
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-06-01
Series:Iranian Journal of Immunology
Subjects:
Lenalidomide
NK cell
Adjuvant
LDH test
Online Access:http://iji.sums.ac.ir/article_39305_6d3e722f67151005e60e2095c02f8d60.pdf

Similar Items

Similar Items